MFDS
- Status: likely_approved
🇰🇷 Ortho-Novum 10/11-21 in South Korea
Ortho-Novum 10/11-21 (Ethinylestradiol) regulatory status in South Korea.
Marketing authorisation
Ortho-Novum 10/11-21 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Bone approved in South Korea
Frequently asked questions
Is Ortho-Novum 10/11-21 approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Ortho-Novum 10/11-21 in South Korea?
Merck & Co. is the originator. The local marketing authorisation holder may differ — check the official source linked above.